# The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes

> **NCT04799327** · PHASE2 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 254 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** SHR20004
- **DRUG:** SHR20004
- **DRUG:** SHR20004
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04799327
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-29
- **Primary completion:** 2022-05-15
- **Final completion:** 2022-05-15
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04799327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04799327, "The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04799327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*